title: Microparticles in health and disease.
abstract: Microparticles (MPs) are small fragments of membrane-bound cytoplasm that are shed from the surface of an activated or apoptotic cell. Recently, their function as vectors of transcellular exchange of biologic information, in addition to better described forms of intercellular communication such as growth factors, cytokines, and chemokines, has become well recognized. Circulating levels of MPs are thought to reflect a balance between cell stimulation, proliferation, and death. The production of MPs is thought to predominately occur by vesiculation or blebbing of the cell membrane. The mechanisms governing the remodeling of the plasma membrane are complex, involving cytoskeletal changes and a shift from normal phospholipid asymmetry. Increased intracellular calcium subsequent to cell activation leads to intracellular increases in several proteins including gelsolin and calpain, as well as the activity of enzymes such as translocase, floppase, and scramblase, which play important roles in the homeostasis of the cell membrane. The membrane vesiculation and phospholipids asymmetry leading to the production of MPs occurs by the complex interplay of the proteins involved. There are several clinical conditions associated with elevated MPs, and most are also associated with an increased risk of thrombosis. Apart from cardiovascular disease and venous thromboembolism, MPs are also elevated in solid tumors with metastatic disease. The measurement of MPs is being regarded as a potential biomarker, given the range of conditions in which they are elevated and the association with prothrombotic states. The utility of measuring MPs as a diagnostic and prognostic marker is currently a subject of intense investigation. The further development of the various methods for the detection and measurement of MPs and prospective clinical trials establishing the utility of such tests will be critical prior to the routine measurement of MPs in the diagnostic laboratory.
authors.affiliation: Department of Haematology level 4, Hunter Haematology Research Group, New Medical Building, Calvary Mater Hospital, Waratah Newcastle, Australia. Anoop.Enjeti@mater.health.nsw.gov.au
authors.forename: Anoop K
authors.initials: AK
authors.lastname: Enjeti
authors.forename: Lisa F
authors.initials: LF
authors.lastname: Lincz
authors.forename: Michael
authors.initials: M
authors.lastname: Seldon
mesh_terms: D017209:Apoptosis / Q000502:physiology; D001777:Blood Coagulation; D055252:Cell-Derived Microparticles / Q000737:chemistry* / Q000378:metabolism*; D006402:Hematologic Diseases / Q000175:diagnosis / Q000378:metabolism; D006801:Humans; D009369:Neoplasms / Q000175:diagnosis / Q000378:metabolism; D013927:Thrombosis / Q000175:diagnosis / Q000378:metabolism